Stocks › DGX

QUEST DIAGNOSTICS INC

DGX·NYSE·United States United States·USD
$258.28
-0.81 (-0.31%)
Close · Nov 20, 2026 · Close Prices from Tiingo.com
DGX
QUEST DIAGNOSTICS INC · NYSE
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
DGXS&P 500 (rebased)
Congress BuyCongress SellInsider BuyInsider SellForm 1448-K ResultsLobbying
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair

Congressional Trades

Recent trades of DGX by members of U.S. Congress · 126 on record · 12 in the last 12 months
All congressional trades →
PoliticianStockTypeFiledTraded
Ro KhannaRo KhannaHouse · D · CA DGXQUEST DIAGNOSTICS INC · Common Stock Sale
$1,001 - $15,000
Nov 5, 2026 Oct 7, 2026 Filing ↗
Ro KhannaRo KhannaHouse · D · CA DGXQUEST DIAGNOSTICS INC · Common Stock Purchase
$1,001 - $15,000
Oct 8, 2026 Sep 4, 2026 Filing ↗
Carol D. MillerCarol D. MillerHouse · R · WV DGXQUEST DIAGNOSTICS INC · Stock Sale
$15,001 - $50,000
Aug 13, 2026 Mar 10, 2025 Filing ↗
Julie JohnsonJulie JohnsonHouse · D · TX DGXQUEST DIAGNOSTICS INC · Stock Sale
$1,001 - $15,000
Aug 5, 2026 Oct 30, 2025 Filing ↗
Julie JohnsonJulie JohnsonHouse · D · TX DGXQUEST DIAGNOSTICS INC · Stock Purchase
$1,001 - $15,000
Aug 5, 2026 Oct 30, 2025 Filing ↗
Alan ArmstrongAlan ArmstrongSenate · R · OK DGXQUEST DIAGNOSTICS INC · Stock Purchase
$1,001 - $15,000
Jul 21, 2026 Mar 30, 2026 Filing ↗
Alan ArmstrongAlan ArmstrongSenate · R · OK DGXQUEST DIAGNOSTICS INC · Stock Purchase
$1,001 - $15,000
Jul 21, 2026 Mar 27, 2026 Filing ↗
Ro KhannaRo KhannaHouse · D · CA DGXQUEST DIAGNOSTICS INC · Common Stock Sale
$1,001 - $15,000
Mar 9, 2026 Feb 17, 2026 Filing ↗
Ro KhannaRo KhannaHouse · D · CA DGXQUEST DIAGNOSTICS INC · Stock Purchase
$1,001 - $15,000
Feb 6, 2026 Jan 29, 2026 Filing ↗
Julia LetlowJulia LetlowHouse · R · LA DGXQUEST DIAGNOSTICS INC · Stock Sale
$1,001 - $15,000
Jan 13, 2026 Jul 24, 2025 Filing ↗
Julia LetlowJulia LetlowHouse · R · LA DGXQUEST DIAGNOSTICS INC · Stock Purchase
$1,001 - $15,000
Jan 13, 2026 Apr 28, 2025 Filing ↗
Julie JohnsonJulie JohnsonHouse · D · TX DGXQUEST DIAGNOSTICS INC · Stock Sale
$1,001 - $15,000
Dec 11, 2025 Nov 3, 2025 Filing ↗
Carol D. MillerCarol D. MillerHouse · R · WV DGXQUEST DIAGNOSTICS INC · Stock Sale
$1,001 - $15,000
Apr 11, 2025 Mar 10, 2025 Filing ↗
Gilbert Ray Cisneros, Jr.Gilbert Ray Cisneros, Jr.House · D · CA DGXQUEST DIAGNOSTICS INC · Stock Sale
$1,001 - $15,000
Feb 11, 2025 Jan 24, 2025 Filing ↗
Ro KhannaRo KhannaHouse · D · CA DGXQUEST DIAGNOSTICS INC · Common Stock Purchase
$1,001 - $15,000
Feb 6, 2025 Jan 17, 2025 Filing ↗
Ro KhannaRo KhannaHouse · D · CA DGXQUEST DIAGNOSTICS INC · Common Stock Sale
$1,001 - $15,000
Jan 8, 2025 Dec 18, 2024 Filing ↗
Ro KhannaRo KhannaHouse · D · CA DGXQUEST DIAGNOSTICS INC · Common Stock Sale
$1,001 - $15,000
Jan 8, 2025 Dec 16, 2024 Filing ↗
Ro KhannaRo KhannaHouse · D · CA DGXQUEST DIAGNOSTICS INC · Stock Purchase
$1,001 - $15,000
Dec 5, 2024 Nov 12, 2024 Filing ↗
Ro KhannaRo KhannaHouse · D · CA DGXQUEST DIAGNOSTICS INC · Common Stock Purchase
$1,001 - $15,000
Dec 5, 2024 Nov 15, 2024 Filing ↗
Earl BlumenauerEarl BlumenauerHouse · D · OR DGXQUEST DIAGNOSTICS INC · Stock Sale
$1,001 - $15,000
May 4, 2024 Apr 4, 2024 Filing ↗
Ro KhannaRo KhannaHouse · D · CA DGXQUEST DIAGNOSTICS INC · CMN Sale
$1,001 - $15,000
Mar 6, 2024 Feb 13, 2024 Filing ↗
Ro KhannaRo KhannaHouse · D · CA DGXQUEST DIAGNOSTICS INC · Common Stock Purchase
$1,001 - $15,000
Mar 6, 2024 Feb 13, 2024 Filing ↗
Tommy TubervilleTommy TubervilleSenate · R · AL DGXQUEST DIAGNOSTICS INC · Stock Sale
$15,001 - $50,000
Feb 14, 2024 Jan 3, 2024 Filing ↗
Ro KhannaRo KhannaHouse · D · CA DGXQUEST DIAGNOSTICS INC · Common Stock Purchase
$1,001 - $15,000
Jan 4, 2024 Dec 4, 2023 Filing ↗
Ro KhannaRo KhannaHouse · D · CA DGXQUEST DIAGNOSTICS INC · Stock Purchase
$1,001 - $15,000
Jan 4, 2024 Dec 5, 2023 Filing ↗

Whale Activity

Position changes in DGX reported for 2026-09-30 by 1219 institutional filers
Increased: 371New: 124Held: 206Decreased: 391Closed: 74No prior filing: 53
  • Increased371
  • New124
  • Held206
  • Decreased391
  • Closed74
  • No prior filing53
FilerSharesValueChange
BlackRock, Inc.9.3M$2.16Bdecreased
VANGUARD CAPITAL MANAGEMENT LLC7.2M$1.68Bdecreased
VANGUARD PORTFOLIO MANAGEMENT LLC6.1M$1.42Bdecreased
STATE STREET CORP5.6M$1.30Bincreased
PRICE T ROWE ASSOCIATES INC /MD/5.0M$1.17Bdecreased
Boston Partners4.6M$1.08Bdecreased
FMR LLC4.5M$1.05Bincreased
GEODE CAPITAL MANAGEMENT, LLC3.2M$734.9Mincreased
JPMORGAN CHASE & CO2.9M$669.9Mdecreased
MORGAN STANLEY2.5M$575.1Mincreased
EdgePoint Investment Group Inc.2.1M$488.9Mdecreased
DIMENSIONAL FUND ADVISORS LP2.0M$466.8Mincreased

Every 13F filer's complete reported book, every quarter since 2013-06-30. 13F itself excludes short positions, cash and most options.

Insider Trading

Net shares bought (+) or sold (−) on the open market by DGX insiders, by quarter · Form 4
-100.0K-50.0K050.0K100.0K2025 Q1: -16.7K2025 Q12025 Q2: -43.5K2025 Q22025 Q3: -53.2K2025 Q32025 Q4: -65.8K2025 Q42026 Q1: -61.8K2026 Q12026 Q2: -18.1K2026 Q22026 Q3: -34.3K2026 Q32026 Q4: -46.8K2026 Q4

Recent Insider Transactions

2,086 transactions on record · newest first
All insider activity →
InsiderTypeSharesPriceValueDate
Deppe Michael JSVP, Corp. Controller & CAO Sale −6,261 $260.17 $1.6M Nov 13, 2026 Form 4 ↗
Deppe Michael JSVP, Corp. Controller & CAO Sale −5,515 $260.17 $1.4M Nov 13, 2026 Form 4 ↗
Plewman PatrickSVP for Diagnostic Services Sale −6,793 $257.34 $1.7M Nov 9, 2026 Form 4 ↗
Plewman PatrickSVP for Diagnostic Services Sale −650 $257.34 $167K Nov 9, 2026 Form 4 ↗
Plewman PatrickSVP for Diagnostic Services Sale −4,274 $257.34 $1.1M Nov 9, 2026 Form 4 ↗
Doherty Catherine T.Executive Vice President Sale −5,990 $246.26 $1.5M Nov 3, 2026 Form 4 ↗
Doherty Catherine T.Executive Vice President Sale −3,818 $245.45 $937K Nov 3, 2026 Form 4 ↗
Doherty Catherine T.Executive Vice President Sale −3,004 $249.40 $749K Nov 3, 2026 Form 4 ↗
Doherty Catherine T.Executive Vice President Sale −2,907 $251.24 $730K Nov 3, 2026 Form 4 ↗
Doherty Catherine T.Executive Vice President Sale −2,877 $250.49 $721K Nov 3, 2026 Form 4 ↗
Doherty Catherine T.Executive Vice President Sale −2,358 $248.38 $586K Nov 3, 2026 Form 4 ↗
Doherty Catherine T.Executive Vice President Sale −1,151 $246.98 $284K Nov 3, 2026 Form 4 ↗
PFEIFFER GARY MDirector · Director Sale −1,203 $243.00 $292K Oct 26, 2026 Form 4 ↗
Davis J. E.CEO and President · Director Sale −10.0K $242.72 $2.4M Sep 1, 2026 Form 4 ↗
PREVOZNIK MICHAEL ESVP & General Counsel Gift −1,000 $0.00 $0 Aug 28, 2026 Form 4 ↗
PREVOZNIK MICHAEL ESVP & General Counsel Sale −430 $244.51 $105K Aug 28, 2026 Form 4 ↗
PREVOZNIK MICHAEL ESVP & General Counsel Sale −6,237 $243.63 $1.5M Aug 28, 2026 Form 4 ↗
PREVOZNIK MICHAEL ESVP & General Counsel Sale −16.0K $242.88 $3.9M Aug 28, 2026 Form 4 ↗
PREVOZNIK MICHAEL ESVP & General Counsel Option exercise +22.7K $112.17 $2.5M Aug 28, 2026 Form 4 ↗
DELANEY MARK ESVP & Chief Commercial Officer Sale −1,600 $235.18 $376K Jul 28, 2026 Form 4 ↗

Fund Holders

Mutual funds and ETFs holding DGX · SEC Form N-PORT
FundSharesValue% of fundAs of
VANGUARD TOTAL STOCK MARKET INDEX FUND
VANGUARD INDEX FUNDS
3.5M$744.9M0.03%Jun 30, 2026
VANGUARD 500 INDEX FUND
VANGUARD INDEX FUNDS
2.9M$607.9M0.04%Jun 30, 2026
VANGUARD MID-CAP INDEX FUND
VANGUARD INDEX FUNDS
2.4M$508.4M0.23%Jun 30, 2026
Fidelity 500 Index Fund
Fidelity Concord Street Trust
1.4M$345.3M0.04%Aug 31, 2026
iShares Core S&P 500 ETF
iShares Trust
1.5M$322.0M0.04%Jun 30, 2026
State Street(R) SPDR(R) S&P 500(R) ETF Trust1.3M$284.3M0.04%Jun 30, 2026
Disciplined Value Mid Cap Fund
John Hancock Funds III
1.2M$259.2M1.12%Jun 30, 2026
JPMorgan Equity Income Fund
JPMorgan Trust II
1.2M$244.4M0.56%Jun 30, 2026
T. Rowe Price Dividend Growth Fund, Inc.1.1M$235.1M0.99%Jun 30, 2026
Disciplined Value Fund
John Hancock Funds III
1.1M$225.7M1.15%Jun 30, 2026

Mutual funds and ETFs whose N-PORT filings list DGX's shares (CUSIP 74834L100), each fund at its latest report since Apr 21, 2026, largest positions first. Bonds, options and short positions are left out.

Activist & Passive Stakes

Schedule 13D / 13G beneficial-ownership filings
  • STATE STREET CORPORATIONSCHEDULE 13G · passive (13G) · 5.6M shares5.0%
    Nov 10, 2026 · ↗
  • T. Rowe Price Associates, Inc.SCHEDULE 13G/A · passive (13G) · 5.4M shares4.9%
    Aug 14, 2026 · ↗
  • BlackRock, Inc.SCHEDULE 13G/A · passive (13G) · 9.3M shares8.4%
    Apr 17, 2025 · ↗

Corporate Lobbying

Estimated quarterly lobbying spending reported under the LDA, filings naming quest diagnostics as client
$0$1.3M$2.5M$3.8M$5.0M2023 Q1: $710K2023 Q2: $1.3M2023 Q3: $710K2023 Q4: $720K20232024 Q1: $1.1M2024 Q2: $710K2024 Q3: $600K2024 Q4: $580K20242025 Q1: $930K2025 Q2: $930K2025 Q3: $860K2025 Q4: $540K20252026 Q1: $880K2026 Q2: $660K2026 Q3: $490K2026
  • FEDERAL STREET STRATEGIES, LLCQUEST DIAGNOSTICS INCORPORATED · 2026 Q3 · HCR, MMM$50K
    Filing ↗
  • QUEST DIAGNOSTICS INCORPORATEDQUEST DIAGNOSTICS INCORPORATED · 2026 Q3 · BUD, HCR, MMM$300K
    Filing ↗
  • TARPLIN, DOWNS & YOUNG, LLCQUEST DIAGNOSTICS · 2026 Q3 · HCR, MMM, BUD$60K
    Filing ↗
  • RED+BLUE STRATEGIESQUEST DIAGNOSTICS INCORPORATED · 2026 Q3 · HCR$80K
    Filing ↗
  • FEDERAL STREET STRATEGIES, LLCQUEST DIAGNOSTICS INCORPORATED · 2026 Q2 · HCR, MMM$50K
    Filing ↗

Government Contracts

Federal awards to quest diagnostics · USAspending
$177.5MAwarded · 263 contracts on record
  • Court Services and Offender Supervision AgencyRSC LAB TEST SERVICES IN FY22$48
    Sep 29, 2022 · ↗
  • Department of Health and Human ServicesNHDP172 C 7569 BPA CALL(S): LABORATORY TESTING SERVICES$144K
    Sep 29, 2026 · ↗
  • Department of Health and Human ServicesNHDP172 C 6286 LAB TEST BPA CALL ORDER$144K
    Sep 29, 2025 · ↗
  • Department of Health and Human ServicesNATIONWIDE CLINICAL LABORATORY TESTING SERVICES NHDP172 C 4657$144K
    Sep 29, 2023 · ↗
  • Department of Health and Human ServicesNATIONWIDE CLINICAL LABORATORY TESTING SERVICES NHDP172 C 4657$57K
    May 22, 2023 · ↗
  • Department of Health and Human ServicesNATIONWIDE CLINICAL LABORATORY TESTING SERVICES NHDP172 C 4366$87K
    Sep 29, 2022 · ↗
  • Department of Health and Human ServicesNATIONWIDE CLINICAL LABORATORY TESTING SERVICES NHDP172 C 3585$17K
    Sep 29, 2021 · ↗
  • Department of Health and Human ServicesNATIONWIDE CLINICAL LABORATORY TESTING SERVICES NHDP172 C 5297$144K
    Sep 29, 2024 · ↗

U.S. Patents

Recent USPTO applications naming QUEST DIAGNOSTICS INC

No USPTO patent applications found for QUEST DIAGNOSTICS INC.

Annual Financials

From DGX's 10-K filings · XBRL
Fiscal yearFY2025FY2024FY2023FY2022FY2021
Revenue$11.04B$9.87B$9.25B$9.88B$10.79B
Operating income$1.56B$1.35B$1.26B$1.43B$2.38B
Net income$992.0M$871.0M$854.0M$946.0M$2.00B
Diluted EPS$8.75$7.69$7.49$7.97$15.55
Operating cash flow$1.89B$1.33B$1.27B$1.72B$2.23B
Cash and equivalents$420.0M$549.0M$686.0M$315.0M$872.0M
Total assets$16.23B$16.15B$14.02B$12.84B$13.61B
Shareholders' equity$7.17B$6.78B$6.31B$5.89B$6.44B

As QUEST DIAGNOSTICS INC tagged them in its 10-K filings: totals for the year on the income and cash-flow lines, values at the year's end on the balance-sheet lines. Latest 10-K, filed Feb 26, 2026 ↗

Stock Splits

Every split and reverse split in the price history
  • 2-for-1Stock splitJun 21, 2005
  • 2-for-1Stock splitJun 1, 2001

Split dates and ratios from the price history · Close Prices from Tiingo.com

Material Events (8-K)

Corporate events filed with the SEC
  • 8-K · Items 2.02, 9.01Results of operationsOct 22, 2026
    EDGAR ↗
  • 8-K · Items 8.01Other eventsOct 22, 2026
    EDGAR ↗
  • 8-K · Items 5.02Officer / director changeOct 6, 2026
    EDGAR ↗
  • 8-K · Items 2.02, 9.01Results of operationsJul 23, 2026
    EDGAR ↗
  • 8-K · Items 5.07Shareholder voteMay 21, 2026
    EDGAR ↗
  • 8-K · Items 1.01, 9.01Material agreementMay 8, 2026
    EDGAR ↗
  • 8-K · Items 8.01, 9.01Other eventsMay 1, 2026
    EDGAR ↗

About QUEST DIAGNOSTICS INC

From SEC EDGAR company records
Industry (SIC 8071)Services-Medical Laboratories
SectorHealthcare
HeadquartersSECAUCUS, NJ
IncorporatedDE
Former namesCORNING CLINICAL LABORATORIES INC